COVID-19 Updates
From the Journals
Vitamin D may protect against COVID-19, especially in Black patients
Feature
COVID-19 variants now detected in more animals, may find hosts in mice
From the Journals
Infliximab weakens COVID-19 antibody response for IBD patients
Anti–COVID-19 antibodies were impaired in patients with IBD treated with infliximab, compared with those on vedolizumab.
From the Journals
COVID-19 may alter gut microbiota
Changes in gut microorganisms may contribute to severe disease and long-term symptoms after the virus clears.
From the Journals
COVID-19 may damage blood vessels in the brain
A postmortem study reveals signs of vascular inflammation in the brains of deceased patients.
From the Journals
Liver disease associated with worse COVID-19 outcomes
More than 90% of patients can develop increased levels of ALT and AST, and these elevations appear to mirror disease severity.
From the Journals
COVID-19 ranks as a leading cause of death in United States
“The current exponential increase in COVID-19 is reaching a calamitous scale in the U.S.”
From the Journals
COVID-19 vaccines: Safe for immunocompromised patients?
Data are limited thus far, and the safety and efficacy of the COVID-19 vaccines in immunocompromised patients remain unknown.
Conference Coverage
Liver injury linked to COVID-19–related coagulopathy
Cells that line the liver's blood vessels produce high levels of factor VIII, a coagulation factor, when they are exposed to interleukin-6, an...
Feature
AMA takes on vaccine misinformation, physician vaccines, racism
The AMA House of Delegates recently issued multiple new policies on controversial topics that many clinicians face on a regular basis.